OA11581A - Compounds, compositions, and methods for stimulating neuronal growth and elongation. - Google Patents

Compounds, compositions, and methods for stimulating neuronal growth and elongation. Download PDF

Info

Publication number
OA11581A
OA11581A OA1200100015A OA1200100015A OA11581A OA 11581 A OA11581 A OA 11581A OA 1200100015 A OA1200100015 A OA 1200100015A OA 1200100015 A OA1200100015 A OA 1200100015A OA 11581 A OA11581 A OA 11581A
Authority
OA
OAPI
Prior art keywords
alkyl
compound
group
substituted
alkenyl
Prior art date
Application number
OA1200100015A
Other languages
English (en)
Inventor
Vincent Kalish
Susumu Katoh
Hiroshi Kawakami
Maria Angelica Linton
Hiroki Tada
John Howard Tatlock
Villafranca J Ernesto
Original Assignee
Agouron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma filed Critical Agouron Pharma
Publication of OA11581A publication Critical patent/OA11581A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
OA1200100015A 1998-07-17 1999-07-15 Compounds, compositions, and methods for stimulating neuronal growth and elongation. OA11581A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9329998P 1998-07-17 1998-07-17
US13288499P 1999-05-06 1999-05-06

Publications (1)

Publication Number Publication Date
OA11581A true OA11581A (en) 2004-07-23

Family

ID=26787372

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200100015A OA11581A (en) 1998-07-17 1999-07-15 Compounds, compositions, and methods for stimulating neuronal growth and elongation.

Country Status (35)

Country Link
US (1) US6630472B1 (et)
EP (1) EP1098897B1 (et)
JP (1) JP2002520413A (et)
KR (1) KR20010071920A (et)
CN (1) CN1318067A (et)
AP (1) AP2001002052A0 (et)
AT (1) ATE268772T1 (et)
AU (1) AU756912B2 (et)
BG (1) BG105268A (et)
BR (1) BR9912423A (et)
CA (1) CA2337377A1 (et)
DE (1) DE69917907T2 (et)
DK (1) DK1098897T3 (et)
EA (1) EA200100149A1 (et)
EE (1) EE200100032A (et)
ES (1) ES2226409T3 (et)
GE (1) GEP20043368B (et)
HR (1) HRP20010118A2 (et)
HU (1) HUP0200637A3 (et)
ID (1) ID27428A (et)
IL (1) IL140676A0 (et)
IS (1) IS5805A (et)
LT (1) LT4850B (et)
LV (1) LV12665B (et)
NO (1) NO20010191L (et)
NZ (1) NZ509211A (et)
OA (1) OA11581A (et)
PL (1) PL345598A1 (et)
PT (1) PT1098897E (et)
SI (1) SI20638A (et)
SK (1) SK462001A3 (et)
TR (1) TR200100122T2 (et)
WO (1) WO2000004020A1 (et)
YU (1) YU2901A (et)
ZA (1) ZA200100320B (et)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818643B1 (en) * 1999-12-08 2004-11-16 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
WO2002089806A1 (en) * 2001-05-10 2002-11-14 Agouron Pharmaceuticals, Inc. Heterobicycles fkbp-ligands
EP2899192A1 (en) * 2014-01-24 2015-07-29 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders
US9914732B2 (en) 2014-01-24 2018-03-13 Max-Planck-Gesellschaft Zur Forderung Der Wissensc Haften E.V. Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5109112A (en) 1989-01-19 1992-04-28 Merck & Co., Inc. FK-506 cytosolic binding protein
US5196352A (en) 1989-01-19 1993-03-23 Merck & Co., Inc. New FK-506 cytosolic binding protein
US5192773A (en) 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds
US5256656A (en) * 1990-07-31 1993-10-26 Nisshin Flour Milling Co., Ltd. Azabicyclo derivatives
US5187166A (en) * 1990-07-31 1993-02-16 Nisshin Flour Milling Co., Ltd. Azabicyclo derivatives and their use as antiemetics
CA2068062A1 (en) 1991-05-07 1992-11-08 Stephen A. Parent Yeast mutants
US5362629A (en) 1991-08-05 1994-11-08 President And Fellows Of Harvard College Detection of immunosuppressants
US5344831A (en) * 1992-01-31 1994-09-06 Nisshin Flour Milling Co., Ltd. Diazabicyclo derivatives
DE4219973A1 (de) 1992-06-19 1993-12-23 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
US5318895A (en) 1992-10-05 1994-06-07 Merck & Co., Inc. Aspergillus niger mutants
US5798355A (en) 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
JP3235913B2 (ja) * 1993-07-30 2001-12-04 エーザイ株式会社 アミノ安息香酸誘導体
US5612350A (en) 1993-11-30 1997-03-18 Abbott Laboratories Macrocyclic immunomodulators with novel cyclohexyl ring replacements
DE4341402A1 (de) 1993-12-04 1995-06-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
US5457182A (en) 1994-02-15 1995-10-10 Merck & Co., Inc. FK-506 cytosolic binding protein, FKBP12.6
US5622866A (en) 1994-06-23 1997-04-22 Merck & Co., Inc. Expression cassettes useful in construction of integrative and replicative expression vectors for Streptomyces
US5696135A (en) 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5614547A (en) 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US6037370A (en) 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5801197A (en) 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5786378A (en) * 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
US5801187A (en) 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
US5780484A (en) 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
US5840736A (en) 1996-11-13 1998-11-24 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5811434A (en) 1996-11-13 1998-09-22 Vertex Pharmacueticals Incorporated Methods and compositions for stimulating neurite growth
PA8442401A1 (es) 1996-12-09 2000-05-24 Guilford Pharm Inc Inhibidores polipropilos de ciclofilina
US5935989A (en) 1996-12-31 1999-08-10 Gpi Nil Holdings Inc. N-linked ureas and carbamates of heterocyclic thioesters
US5874449A (en) 1996-12-31 1999-02-23 Gpi Nil Holdings, Inc. N-linked sulfonamides of heterocyclic thioesters
US5721256A (en) 1997-02-12 1998-02-24 Gpi Nil Holdings, Inc. Method of using neurotrophic sulfonamide compounds
ZA98825B (en) 1997-02-27 1998-10-19 Guilford Pharm Inc Method of using neurotrophic carbamates and ureas
US5846979A (en) 1997-02-28 1998-12-08 Gpi Nil Holdings, Inc. N-oxides of heterocyclic esters, amides, thioesters, and ketones

Also Published As

Publication number Publication date
BG105268A (en) 2001-11-30
DE69917907T2 (de) 2005-06-30
TR200100122T2 (tr) 2001-08-21
DK1098897T3 (da) 2004-10-18
ATE268772T1 (de) 2004-06-15
HUP0200637A2 (en) 2002-08-28
ID27428A (id) 2001-04-05
YU2901A (sh) 2004-05-12
CA2337377A1 (en) 2000-01-27
KR20010071920A (ko) 2001-07-31
WO2000004020A1 (en) 2000-01-27
LV12665A (en) 2001-05-20
SI20638A (sl) 2002-02-28
SK462001A3 (en) 2002-02-05
LT2001012A (en) 2001-07-25
PT1098897E (pt) 2004-10-29
JP2002520413A (ja) 2002-07-09
NO20010191D0 (no) 2001-01-12
HUP0200637A3 (en) 2003-05-28
NO20010191L (no) 2001-03-16
EA200100149A1 (ru) 2001-08-27
AU756912B2 (en) 2003-01-23
AP2001002052A0 (en) 2001-03-31
ZA200100320B (en) 2002-07-11
BR9912423A (pt) 2001-06-05
IL140676A0 (en) 2002-02-10
HRP20010118A2 (en) 2002-02-28
EE200100032A (et) 2002-06-17
US6630472B1 (en) 2003-10-07
NZ509211A (en) 2002-10-25
IS5805A (is) 2001-01-12
EP1098897B1 (en) 2004-06-09
GEP20043368B (en) 2004-04-13
CN1318067A (zh) 2001-10-17
ES2226409T3 (es) 2005-03-16
EP1098897A1 (en) 2001-05-16
PL345598A1 (en) 2001-12-17
LT4850B (lt) 2001-10-25
AU4996399A (en) 2000-02-07
LV12665B (lv) 2001-11-20
DE69917907D1 (de) 2004-07-15

Similar Documents

Publication Publication Date Title
US6544987B2 (en) Compounds, compositions, and methods for stimulating neuronal growth and elongation
ES2785498T3 (es) Ftalazinonas e isoquinolinonas como inhibidores de ROCK
EP3481828B1 (en) Spiro-fused cyclic ureas as inhibitors of rock
JP5232178B2 (ja) C型肝炎の治療のための化合物
JP5416710B2 (ja) シクロプロピル縮合インドロベンズアゼピンhcvns5b阻害剤
EP2382191B1 (en) Novel benzenesulfonamides as calcium channel blockers
JP2020505328A (ja) Rhoキナーゼ阻害剤としてのチロシンアミド誘導体
US8129417B2 (en) Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers
CA2936241A1 (en) Azepane derivatives and methods of treating hepatitis b infections
MX2007001683A (es) Inhibidores de la replicacion del virus de la hepatitis c (vhc).
CN112752757B (zh) 作为rho-激酶抑制剂的酪氨酸酰胺衍生物
OA11581A (en) Compounds, compositions, and methods for stimulating neuronal growth and elongation.
WO2011149995A1 (en) Novel substituted octahydrocyclopenta [c]pyrrol-4-amines as calcium channel blockers
CA3234429A1 (en) Ras inhibitors, compositions and methods of use thereof
KR102025415B1 (ko) C형 간염 바이러스 억제 화합물, 약학 조성물 및 그 응용
IL101560A (en) Compressed diazepines, their preparation and pharmaceutical preparations containing them
CZ2001105A3 (cs) Sloučeniny, prostředky a způsoby stimulace neuronálního růstu a prodloužení
EP3045448A1 (en) Nitrogen-containing saturated heterocyclic compound
MXPA01000441A (en) Compounds, compositions, and methods for stimulating neuronal growth and elongation
EP2978760B1 (en) Cyclic n-acyl o-amino phenol cbi derivative
WO2019043103A1 (en) 3-HYDROXY-IMIDAZOLIDIN-4-ONE COMPOUNDS AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE
JP2007530555A (ja) テトラヒドロ−β−カルボリン化合物及びその使用